T cell derived cytokines in psoriatic arthritis synovial fluids

Annals of the Rheumatic Diseases

Volumn 57, Issue 11, 1998, Pages 691-693

  Partsch, Gerald ^a   Wagner, Ernst ^b   Leeb, Burkhard F ^c   Bröll, Hans ^d   Dunky, Attila ^b   Smolen, Josef S ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c Municipal Hospital   (Austria)

^d KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOTOXIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031796055     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.11.691     Document Type: Article

References (17)

1. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:246-9.
2. Smolen JS, Tohidast-Akrad M, Gal A, Kunaver M, Eberl G, Zenz P, et al. The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol 1996;25:1-4.
3. Panayi GS. Immunology of psoriasis and psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:419-27.
4. Soren A, Waugh TR. Changes in the synovial membrane in psoriatic arthritis. Rev Rhum 1982;49:671-6.
5. Dechanet J, Rissoan MC, Banchereau J, Miossec P. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes. Cytokine 1995;7:176-83.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Altman R. Classification of disease: osteoarthritis. Semin Arthritis Rheum 1991;20 (suppl 2):40-7.
8. + T cells in psoriatic arthritis synovial effusions. Br J Rheumatol 1996;35 (suppl 1):160.
9. Schlaak JF, Pfers I, Meyer zum Büschenfelde K-H, Märker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996;14:155-62.
10. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
11. Miossec P, Naviliat M, Dupuy d'Angeac A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990;33:1180-7.
12. Howard M, O'Garra A, Ishida H, Malefyt RDW, de Vries J. Biological properties of interleukin 10. J Clin Immunol 1992;12:239-47.
13. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36:893-900.
14. Partsch G, Steiner G, Leeb BF, Dunky A, Bröll H, Smolen JS. Highly increased levels of tumor necrosis factor-α and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol 1997;24:518-23.
15. Gladman DD. Natural history of psoriatic arthritis. In: Wright V, Helliwell P, eds. Psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:379-94.
16. Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 1995;13:459-63.
17. Olivieri I, Salvarani C, Olivieri I, Cantini F, Macchioni L, Padula A, et al. Therapy with cyclosporine in psoriatic arthritis. Semin Arthritis Rheum 1997;27:36-43.